Downregulation of TOP2 modulates neurodegeneration caused by GGGGCC expanded repeats.
暂无分享,去创建一个
P. Jin | H. Feng | Hao Wu | B. Tang | Feiran Zhang | Lu Shen | Junling Wang | Bin Jiao | Mengli Wang | Han Bao
[1] O. Bouchez,et al. Transcription-associated topoisomerase activities control DNA-breaks production by G-quadruplex ligands , 2020, bioRxiv.
[2] Ž. Skok,et al. Dual inhibitors of human DNA topoisomerase II and other cancer-related targets. , 2020, Journal of medicinal chemistry.
[3] M. Kiaei,et al. Profilin1 biology and its mutation, actin(g) in disease , 2016, Cellular and Molecular Life Sciences.
[4] M. Cazzaniga,et al. Benefit of low‐dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS , 2016, International journal of cancer.
[5] Eric W. Danielson,et al. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity , 2016, Proceedings of the National Academy of Sciences.
[6] B. Patel,et al. Poster 280 ALS Masked by Breast Cancer History and Low Back Pain: A Case Report , 2016, PM & R : the journal of injury, function, and rehabilitation.
[7] Mackenzie W. Mathis,et al. ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks , 2016, Nature Neuroscience.
[8] Jian Jin,et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation , 2016, Science.
[9] G. Sobue,et al. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[10] Sean J. Miller,et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport , 2015, Nature.
[11] Markus Weber,et al. Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS , 2015, Molecular Neurodegeneration.
[12] Christian A. Ross,et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS , 2015, Nature Neuroscience.
[13] Stuart A. Wilson,et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions , 2014, Brain : a journal of neurology.
[14] L. Petrucelli,et al. Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion , 2013, Science Translational Medicine.
[15] E. Kremmer,et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins , 2013, Acta Neuropathologica.
[16] W. Le,et al. Genetics of amyotrophic lateral sclerosis: an update , 2013, Molecular Neurodegeneration.
[17] M. Dowsett,et al. Biomarkers for the clinical management of breast cancer: International perspective , 2013, International journal of cancer.
[18] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[19] Chadwick M. Hales,et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration , 2013, Proceedings of the National Academy of Sciences.
[20] E. Kremmer,et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.
[21] M. Swash,et al. Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.
[22] Kevin F. Bieniek,et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS , 2013, Neuron.
[23] Hao Wu,et al. A new shrinkage estimator for dispersion improves differential expression detection in RNA-seq data , 2012, Biostatistics.
[24] K. Tsai,et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43 , 2012, Proceedings of the National Academy of Sciences.
[25] Gene W. Yeo,et al. Misregulated RNA processing in amyotrophic lateral sclerosis , 2012, Brain Research.
[26] Lukas Burger,et al. Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state , 2012, Proceedings of the National Academy of Sciences.
[27] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[28] S. Pereson,et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study , 2012, The Lancet Neurology.
[29] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[30] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[31] A. Aguilera,et al. Topological constraints impair RNA polymerase II transcription and causes instability of plasmid-borne convergent genes , 2011, Nucleic acids research.
[32] D. Cleveland,et al. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.
[33] Holger Sültmann,et al. ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and Prediction , 2010, Clinical Cancer Research.
[34] J. Landers,et al. RNA processing pathways in amyotrophic lateral sclerosis , 2010, neurogenetics.
[35] W. Tourtellotte,et al. Abnormal sympathetic nervous system development and physiological dysautonomia in Egr3-deficient mice , 2008, Development.
[36] A. Wells,et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness , 2007, British Journal of Cancer.
[37] G. Sobue,et al. [Gene expression profile of spinal ventral horn in ALS]. , 2007, Brain and nerve = Shinkei kenkyu no shinpo.
[38] G. Sobue,et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis , 2005, Annals of neurology.
[39] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[40] M. Mattern,et al. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[41] W. Earnshaw,et al. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[42] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.